Epidemiology of Parkinson Disease.
暂无分享,去创建一个
[1] B. Bloem,et al. Effectiveness of multidisciplinary care for Parkinson's disease: A randomized, controlled trial , 2013, Movement disorders : official journal of the Movement Disorder Society.
[2] P. Martínez-Martín,et al. Relationship between sleep disorders and other non-motor symptoms in Parkinson's disease. , 2013, Parkinsonism & related disorders.
[3] Bastiaan R Bloem,et al. Gender differences in Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[4] A. Minagar,et al. The spinal cord: a review of functional neuroanatomy. , 2013, Neurologic clinics.
[5] M. Breteler,et al. Epidemiology of Parkinson's disease , 2006, The Lancet Neurology.
[6] Y. Ben-Shlomo,et al. Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies. , 2011, The Cochrane database of systematic reviews.
[7] J. Jankovic,et al. Parkinson disease subtypes. , 2014, JAMA neurology.
[8] S. Bettiol,et al. Alcohol Consumption and Parkinson’s Disease Risk: A Review of Recent Findings , 2015, Journal of Parkinson's disease.
[9] J. Duarte,et al. Natural History of Parkinson's Disease in the Province of Segovia: Disability in a 20 Years Longitudinal Study , 2015, Neurodegenerative Diseases.
[10] C. Colosio,et al. The role of pesticide exposure in the genesis of Parkinson's disease: epidemiological studies and experimental data. , 2013, Toxicology.
[11] N. Bajaj,et al. Does a specialist unit improve outcomes for hospitalized patients with Parkinson's disease? , 2014, Parkinsonism & related disorders.
[12] A. Kishore,et al. Do nonmotor symptoms in Parkinson's disease differ from normal aging? , 2011, Movement disorders : official journal of the Movement Disorder Society.
[13] D. Aarsland,et al. A systematic review of prevalence studies of depression in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[14] A. Berardelli,et al. Sleep disorders in Parkinson’s disease , 1998, Journal of Neurology.
[15] R. Hauser,et al. Nonmotor symptoms of Parkinson’s disease , 2006, Expert review of neurotherapeutics.
[16] Pablo Martinez-Martin,et al. Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients , 2007, Movement disorders : official journal of the Movement Disorder Society.
[17] K. Winge. Lower urinary tract dysfunction in patients with parkinsonism and other neurodegenerative disorders. , 2015, Handbook of clinical neurology.
[18] D. Aarsland,et al. Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease , 2012, Journal of Neurology.
[19] P. Valkovič,et al. Pain in Parkinson´s Disease: A Cross-Sectional Study of Its Prevalence, Types, and Relationship to Depression and Quality of Life , 2015, PloS one.
[20] Samuel M. Goldman,et al. EPIDEMIOLOGY OF PARKINSON'S DISEASE , 1996, Neurologic Clinics.
[21] G. Gillies,et al. Sex differences in Parkinson’s disease , 2014, Frontiers in Neuroendocrinology.
[22] R. Nussbaum,et al. Alzheimer's disease and Parkinson's disease. , 2003, The New England journal of medicine.
[23] E. Pekkonen,et al. Gut microbiota are related to Parkinson's disease and clinical phenotype , 2015, Movement disorders : official journal of the Movement Disorder Society.
[24] Günther Deuschl,et al. MDS research criteria for prodromal Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[25] G. Halliday,et al. The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years , 2008, Movement disorders : official journal of the Movement Disorder Society.
[26] John D Sorkin,et al. Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. , 2013, JAMA neurology.
[27] P. Tuite. Phase II safety, tolerability, and dose selection study of isradipine as a potential disease‐modifying intervention in early Parkinson's disease (STEADY‐PD) , 2013, Movement disorders : official journal of the Movement Disorder Society.
[28] Edo Richard,et al. Apathy in Parkinson's disease: A systematic review and meta‐analysis , 2015, Movement disorders : official journal of the Movement Disorder Society.
[29] K. Safranow,et al. Ophthalmological Features of Parkinson Disease , 2014, Medical science monitor : international medical journal of experimental and clinical research.
[30] B. Bloem,et al. Artistic occupations are associated with a reduced risk of Parkinson’s disease , 2015, Journal of Neurology.
[31] J. Jankovic,et al. Functional decline in Parkinson disease. , 2001, Archives of neurology.
[32] J. Parkinson. An Essay on the Shaking Palsy , 2002 .
[33] C. Tanner,et al. Traumatic brain injury in later life increases risk for Parkinson disease , 2015, Annals of neurology.
[34] D. Aarsland,et al. A systematic review of prevalence studies of dementia in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.
[35] J. Hardy,et al. Milestones in PD genetics , 2011, Movement disorders : official journal of the Movement Disorder Society.
[36] A. Nicholas,et al. Nonmotor symptoms in Parkinson's disease: expanding the view of Parkinson's disease beyond a pure motor, pure dopaminergic problem. , 2013, Neurologic clinics.
[37] R. Hauser,et al. Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease , 2008, Nature Medicine.
[38] A. Seidler,et al. Diet and Parkinson's disease I , 1996, Neurology.
[39] B. Ritz,et al. Head injury and risk for Parkinson disease , 2015, Neurology.
[40] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[41] H. Braak,et al. Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology , 2006, Neuroscience Letters.
[42] Xiang Gao,et al. Prospective study of statin use and risk of Parkinson disease. , 2012, Archives of neurology.
[43] C. Adler,et al. MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI , 2011, Movement disorders : official journal of the Movement Disorder Society.
[44] S. Cheon,et al. Nonmotor symptoms more closely related to Parkinson's disease: Comparison with normal elderly , 2013, Journal of the Neurological Sciences.
[45] D. Aarsland,et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.
[46] J. Perlmutter,et al. Neurologist care in Parkinson disease , 2011, Neurology.
[47] A. Lees,et al. Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD , 2008, Neurology.
[48] Richard L. Doty,et al. Olfactory dysfunction in Parkinson disease , 2012, Nature Reviews Neurology.
[49] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[50] J. Friedman,et al. Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. , 2014, JAMA neurology.
[51] R. Pfeiffer. Non-motor symptoms in Parkinson's disease. , 2016, Parkinsonism & related disorders.
[52] E. Horváth-Puhó,et al. Vagotomy and subsequent risk of Parkinson's disease , 2015, Annals of neurology.
[53] Bastiaan R Bloem,et al. Nonpharmacological treatments for patients with Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[54] L. Rushton,et al. Pesticides and Parkinson’s Disease—Is There a Link? , 2005, Environmental Health Perspectives.
[55] R. Sakakibara,et al. A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders , 2016, Neurourology and urodynamics.
[56] B. Ritz,et al. Parkinson disease and smoking revisited , 2014, Neurology.
[57] Bradley F. Boeve,et al. REM Sleep Behavior Disorder and REM Sleep Without Atonia as an Early Manifestation of Degenerative Neurological Disease , 2012, Current Neurology and Neuroscience Reports.
[58] Y. Ben-Shlomo,et al. The motor phenotype of Parkinson's disease in relation to age at onset , 2011, Movement disorders : official journal of the Movement Disorder Society.
[59] Z. Mari,et al. The past, present, and future of telemedicine for Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.
[60] D. Aarsland,et al. Changes in motor subtype and risk for incident dementia in Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.
[61] M. Giugliano,et al. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration , 2015, Nature.
[62] W. Poewe,et al. Mortality in Parkinson's disease, a 20‐year follow‐up study , 2009, Movement disorders : official journal of the Movement Disorder Society.